ACM
ABMD

Apex Capital Management’s Abiomed Inc ABMD Stock Holding History

Apex Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$26.4M Buy
278,326
+44,570
+19% +$3.76M 0.58% 66
2015
Q4 		$21.1M Buy
233,756
+16,440
+8% +$1.4M 0.47% 70
2015
Q3 		$20.2M Sell
217,316
-38,347
-15% -$3.38M 0.46% 72
2015
Q2 		$16.8M Buy
255,663
+35,329
+16% +$2.35M 0.36% 80
2015
Q1 		$15.8M Buy
220,334
+49,017
+29% +$2.66M 0.37% 75
2014
Q4 		$6.52M Buy
171,317
+9,973
+6% +$315K 0.17% 108
2014
Q3 		$4.01M Buy
161,344
+16,438
+11% +$416K 0.12% 135
2014
Q2 		$3.64M Buy
144,906
+19,341
+15% +$450K 0.11% 141
2014
Q1 		$3.27M Buy
125,565
+16,418
+15% +$454K 0.12% 144
2013
Q4 		$2.92M Sell
109,147
-984
-0.9% -$24.3K 0.11% 144
2013
Q3 		$2.1M Sell
110,131
-17,430
-14% -$398K 0.09% 167
2013
Q2 		$2.75M Buy
+127,561
New +$2.56M 0.13% 122

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Apex Capital Management's ABMD Position: Q1 2016 in Review

Apex Capital Management increased its Abiomed Inc (ABMD) stake by 19% in Q1 2016, buying an estimated $3.76M and bringing the position to 278,326 shares worth $26.4M. The position accounts for 0.58% of the portfolio, ranked #66.

Apex Capital Management first reported a position in ABMD in Q2 2013 and has held it in 12 quarters since. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

  • Apex Capital Management held 278,326 shares of Abiomed Inc worth $26.4M as of Q1 2016.
  • Apex Capital Management bought 44,570 Abiomed Inc shares in Q1 2016, an estimated $3.76M.
  • Abiomed Inc made up 0.58% of Apex Capital Management's portfolio in Q1 2016, its #66 holding.
  • Apex Capital Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 12 quarters since.
  • 274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.